Sheaff Brock Investment Advisors, LLC Abbott Laboratories Transaction History

Sheaff Brock Investment Advisors, LLC

  • $1.13 Billion
  • Q3 2024

A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 5,865 shares of ABT stock, worth $688,316. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,865
Previous 5,913 0.81%
Holding current value
$688,316
Previous $614,000 8.79%
% of portfolio
0.06%
Previous 0.06%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$100.07 - $118.13 $4,803 - $5,670
-48 Reduced 0.81%
5,865 $668,000
Q2 2024

Jul 30, 2024
SELL
$100.73 - $112.44 $213,950 - $238,822
-2,124 Reduced 26.43%
5,913 $614,000
Q1 2024

May 14, 2024
SELL
$109.52 - $120.96 $266,243 - $294,053
-2,431 Reduced 23.22%
8,037 $913,000
Q4 2023

Feb 08, 2024
SELL
$90.19 - $110.4 $48,973 - $59,947
-543 Reduced 4.93%
10,468 $1.15 Million
Q3 2023

Nov 08, 2023
BUY
$95.53 - $114.62 $13,469 - $16,161
141 Added 1.3%
11,011 $1.07 Million
Q2 2023

Aug 08, 2023
SELL
$100.78 - $112.29 $150,464 - $167,648
-1,493 Reduced 12.08%
10,870 $1.19 Million
Q1 2023

May 01, 2023
BUY
$96.86 - $114.01 $774 - $912
8 Added 0.06%
12,363 $1.25 Million
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $7,889 - $9,256
83 Added 0.68%
12,355 $1.36 Million
Q3 2022

Nov 03, 2022
SELL
$96.76 - $112.03 $24,673 - $28,567
-255 Reduced 2.04%
12,272 $1.19 Million
Q2 2022

Aug 02, 2022
SELL
$102.07 - $123.37 $12,146 - $14,681
-119 Reduced 0.94%
12,527 $1.36 Million
Q1 2022

May 06, 2022
SELL
$114.02 - $139.04 $32,951 - $40,182
-289 Reduced 2.23%
12,646 $1.5 Million
Q4 2021

Feb 03, 2022
SELL
$115.53 - $141.46 $109,291 - $133,821
-946 Reduced 6.82%
12,935 $1.82 Million
Q3 2021

Nov 03, 2021
BUY
$116.66 - $129.06 $383,694 - $424,478
3,289 Added 31.05%
13,881 $1.64 Million
Q2 2021

Jun 02, 2022
BUY
$105.79 - $124.53 $50,038 - $58,902
473 Added 4.67%
10,592 $1.23 Million
Q2 2021

Aug 16, 2021
SELL
$105.79 - $124.53 $44,960 - $52,925
-425 Reduced 4.03%
10,119 $1.17 Million
Q1 2021

Jun 02, 2022
BUY
$108.84 - $128.23 $29,604 - $34,878
272 Added 2.65%
10,544 $1.26 Million
Q1 2021

May 11, 2021
SELL
$108.84 - $128.23 $119,070 - $140,283
-1,094 Reduced 9.63%
10,272 $1.23 Million
Q4 2020

Feb 01, 2021
SELL
$105.0 - $114.42 $22,470 - $24,485
-214 Reduced 1.85%
11,366 $1.24 Million
Q3 2020

Oct 30, 2020
BUY
$91.64 - $111.29 $37,480 - $45,517
409 Added 3.66%
11,580 $1.26 Million
Q2 2020

Aug 07, 2020
BUY
$76.57 - $98.0 $180,475 - $230,986
2,357 Added 26.74%
11,171 $1.02 Million
Q1 2020

Apr 30, 2020
SELL
$62.82 - $91.86 $5,528 - $8,083
-88 Reduced 0.99%
8,814 $696,000
Q4 2019

Jan 29, 2020
BUY
$78.51 - $87.4 $628 - $699
8 Added 0.09%
8,902 $773,000
Q3 2019

Oct 28, 2019
SELL
$81.84 - $88.74 $45,912 - $49,783
-561 Reduced 5.93%
8,894 $744,000
Q2 2019

Jul 31, 2019
SELL
$72.88 - $85.0 $33,087 - $38,590
-454 Reduced 4.58%
9,455 $795,000
Q1 2019

Apr 29, 2019
BUY
$66.22 - $80.06 $23,772 - $28,741
359 Added 3.76%
9,909 $792,000
Q4 2018

Jan 28, 2019
SELL
$65.56 - $74.27 $165,604 - $187,606
-2,526 Reduced 20.92%
9,550 $691,000
Q3 2018

Nov 09, 2018
BUY
$60.81 - $73.36 $59,228 - $71,452
974 Added 8.77%
12,076 $886,000
Q2 2018

Jul 31, 2018
SELL
$57.57 - $63.54 $49,740 - $54,898
-864 Reduced 7.22%
11,102 $677,000
Q1 2018

May 03, 2018
BUY
$56.27 - $63.62 $7,258 - $8,206
129 Added 1.09%
11,966 $717,000
Q4 2017

Feb 12, 2018
SELL
$53.68 - $57.47 $235,172 - $251,776
-4,381 Reduced 27.01%
11,837 $676,000
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $10,140 - $11,318
211 Added 1.32%
16,218 $865,000
Q2 2017

Aug 09, 2017
BUY
N/A
16,007
16,007 $778,000

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email